Validations: Transfers, Robustness & Routine Checks

Stability Shells and CCI: Pull Points That Matter

Stability Shells and CCI: Pull Points That Matter Introduction to Container Closure Integrity (CCI) Container Closure Integrity (CCI) is a critical aspect of pharmaceutical quality assurance, ensuring that sterile products remain uncontaminated and stable throughout their shelf life. It is a direct regulatory requirement under cGMP regulations enforced by the US FDA and is integral to meeting standards set by…

Continue Reading Stability Shells and CCI: Pull Points That Matter

Integrating CCI With Visual/AIS Programs

Integrating CCI With Visual/AIS Programs In the pharmaceutical industry, ensuring the integrity of container closure systems (CCS) is crucial for the safety and efficacy of drug products. Regulatory agencies such as the US FDA, EMA, and the MHRA have set stringent guidelines that necessitate the integration of advanced leak detection methods into the container closure integrity (CCI) program. This guide…

Continue Reading Integrating CCI With Visual/AIS Programs

Mock Recall/Inspection Readiness for CCI

Mock Recall/Inspection Readiness for CCI Mock Recall/Inspection Readiness for CCI Introduction to Container Closure Integrity (CCI) In the pharmaceutical industry, ensuring the integrity of container closures is paramount for product safety and efficacy. Container Closure Integrity (CCI) testing is a vital part of the quality control process, assessing whether the package maintains a sterile barrier, thereby preventing contamination and ensuring…

Continue Reading Mock Recall/Inspection Readiness for CCI

Blister/BFS/Device CCI: Special Transfer Considerations

Blister/BFS/Device CCI: Special Transfer Considerations Understanding Container Closure Integrity (CCI) Container Closure Integrity (CCI) is an essential aspect of pharmaceutical product manufacturing, as it ensures that a product remains sterile and free from contaminants throughout its shelf life. With regulations from bodies such as the US FDA, EMA, and MHRA emphasizing compliance with Good Manufacturing Practices (GMP), organizations must adopt…

Continue Reading Blister/BFS/Device CCI: Special Transfer Considerations

Automation Effects: Robots, Nests, and Fixturing

Automation Effects: Robots, Nests, and Fixturing Automation Effects: Robots, Nests, and Fixturing Introduction to Container Closure Integrity (CCI) Container Closure Integrity (CCI) is a critical component in the pharmaceutical industry’s commitment to ensuring the safety, efficacy, and quality of drug products. It encompasses various methodologies that guarantee drug products remain sterile, stable, and uncontaminated throughout their shelf-life. This tutorial focuses…

Continue Reading Automation Effects: Robots, Nests, and Fixturing

Change Control Hooks: Verification vs Re-Validation

Change Control Hooks: Verification vs Re-Validation Change Control Hooks: Verification vs Re-Validation Understanding Change Control in Pharmaceutical Validation Change control serves as a crucial mechanism in the pharmaceutical industry, ensuring that changes to processes, systems, and products do not adversely affect the quality, safety, and efficacy of pharmaceuticals. This systematic approach entails the validation of every aspect of the operation,…

Continue Reading Change Control Hooks: Verification vs Re-Validation

Data Integrity: Audit Trails and Electronic Records

Data Integrity: Audit Trails and Electronic Records Data Integrity: Audit Trails and Electronic Records Introduction to Container Closure Integrity (CCI) The pharmaceutical industry heavily relies on the integrity of its container closure systems to ensure the safety and efficacy of products. Container closure integrity (CCI) is critical in maintaining the sterility of products, particularly those in sterile formulations. This article…

Continue Reading Data Integrity: Audit Trails and Electronic Records

Supplier/Service Lab Transfers: SLAs and Oversight

<!– –> Supplier/Service Lab Transfers: SLAs and Oversight Understanding Supplier/Service Lab Transfers: SLAs and Oversight Introduction to Container Closure Integrity (CCI) Container Closure Integrity (CCI) is a critical quality attribute in the pharmaceutical industry, ensuring that pharmaceutical products remain free from contamination throughout their shelf life. Inadequate closure integrity can lead to product failures, impacting patient safety and regulatory compliance….

Continue Reading Supplier/Service Lab Transfers: SLAs and Oversight

Alignment to USP : Protocol Language That Works

Alignment to USP : Protocol Language That Works Alignment to USP : Protocol Language That Works The achievement of container closure integrity (CCI) is a fundamental aspect of the pharmaceutical manufacturing process, particularly in the production of sterile products. This tutorial provides a comprehensive, step-by-step guide for alignment with the United States Pharmacopeia (USP) standards, specifically focusing on advanced methods…

Continue Reading Alignment to USP : Protocol Language That Works

Equivalence Criteria in Transfers: Stats and Acceptance

Equivalence Criteria in Transfers: Stats and Acceptance The pharmaceutical industry is under constant scrutiny to maintain product integrity and compliance with regulatory standards such as those set by the US FDA, EMA, and MHRA. One critical aspect of this integrity is the assessment of container closure systems’ efficiency, known as Container Closure Integrity (CCI). This tutorial provides a comprehensive guide…

Continue Reading Equivalence Criteria in Transfers: Stats and Acceptance